Login
$ACTU
$0.26 -$0.01 (2.99%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Daniel M. Schmitt Also a director
President, Chief Executive Officer and Director
64 Not stated $2,166,522
Paul Lytle
Chief Financial Officer
58 Since 2024
2 years
$1,006,361
Andrew P. Mazar
Chief Operating Officer
64 Since 2022
4 years
$1,419,569

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 6, 2026 · updated by the 8-K of May 6, 2026

Directors
8
serving now
Independent
6 of 7
stated in the proxy; 1 not stated
Average tenure
5.3 years
from year joined
Director Age On board Independent Committees Other public boards 2025 pay Source
Daniel M. Schmitt
64 2015
11 years
Not independent None stated None stated Paid as CEO
Aaron G.L. Fletcher, Ph.D.
45 2015
11 years
Independent None stated Cognition Therapeutics, Inc. $181,995
Jason Keyes
55 2024
2 years
Independent
Audit Committee · Chair
None stated $162,995
Amy Ronneberg
52 2024
2 years
Independent
Audit Committee
None stated $159,495
Roger Sawhney
56 2024
2 years
Independent
Compensation Committee
Arbutus Biopharma $159,495
Todd Thomson
65 2022
4 years
Independent None stated Sivers Semiconductors $147,995
Dan Zabrowski
66 2021
5 years
Independent
Compensation Committee · Chair
None stated Not stated
Martin H. Huber Joined May 1, 2026
- - -
Nominating and Corporate Governance Committee
- -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 6, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support